PortfoliosLab logo
UTMD vs. DHR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between UTMD and DHR is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

UTMD vs. DHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

UTMD:

-0.87

DHR:

-0.81

Sortino Ratio

UTMD:

-1.42

DHR:

-1.12

Omega Ratio

UTMD:

0.83

DHR:

0.85

Calmar Ratio

UTMD:

-0.33

DHR:

-0.66

Martin Ratio

UTMD:

-1.09

DHR:

-1.42

Ulcer Index

UTMD:

16.89%

DHR:

18.50%

Daily Std Dev

UTMD:

18.83%

DHR:

30.34%

Max Drawdown

UTMD:

-55.58%

DHR:

-65.30%

Current Drawdown

UTMD:

-52.72%

DHR:

-34.56%

Fundamentals

Market Cap

UTMD:

$178.91M

DHR:

$136.31B

EPS

UTMD:

$3.80

DHR:

$5.15

PE Ratio

UTMD:

14.49

DHR:

36.87

PEG Ratio

UTMD:

0.00

DHR:

1.86

PS Ratio

UTMD:

4.56

DHR:

5.72

PB Ratio

UTMD:

1.51

DHR:

2.67

Total Revenue (TTM)

UTMD:

$39.27M

DHR:

$23.82B

Gross Profit (TTM)

UTMD:

$22.41M

DHR:

$14.23B

EBITDA (TTM)

UTMD:

$14.66M

DHR:

$7.17B

Returns By Period

In the year-to-date period, UTMD achieves a -9.91% return, which is significantly higher than DHR's -17.15% return. Over the past 10 years, UTMD has underperformed DHR with an annualized return of 1.74%, while DHR has yielded a comparatively higher 18.26% annualized return.


UTMD

YTD

-9.91%

1M

5.52%

6M

-14.72%

1Y

-17.79%

3Y*

-12.50%

5Y*

-9.59%

10Y*

1.74%

DHR

YTD

-17.15%

1M

-3.46%

6M

-20.56%

1Y

-25.70%

3Y*

-6.30%

5Y*

5.57%

10Y*

18.26%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Utah Medical Products, Inc.

Danaher Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

UTMD vs. DHR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTMD
The Risk-Adjusted Performance Rank of UTMD is 1515
Overall Rank
The Sharpe Ratio Rank of UTMD is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of UTMD is 66
Sortino Ratio Rank
The Omega Ratio Rank of UTMD is 88
Omega Ratio Rank
The Calmar Ratio Rank of UTMD is 2929
Calmar Ratio Rank
The Martin Ratio Rank of UTMD is 2323
Martin Ratio Rank

DHR
The Risk-Adjusted Performance Rank of DHR is 99
Overall Rank
The Sharpe Ratio Rank of DHR is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of DHR is 1010
Sortino Ratio Rank
The Omega Ratio Rank of DHR is 1010
Omega Ratio Rank
The Calmar Ratio Rank of DHR is 1010
Calmar Ratio Rank
The Martin Ratio Rank of DHR is 88
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UTMD vs. DHR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current UTMD Sharpe Ratio is -0.87, which is comparable to the DHR Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of UTMD and DHR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

UTMD vs. DHR - Dividend Comparison

UTMD's dividend yield for the trailing twelve months is around 2.20%, more than DHR's 0.60% yield.


TTM20242023202220212020201920182017201620152014
UTMD
Utah Medical Products, Inc.
2.20%1.96%1.41%1.16%2.86%1.33%1.02%1.31%1.31%1.44%1.75%1.67%
DHR
Danaher Corporation
0.60%0.47%0.43%0.38%0.26%0.32%0.44%0.62%0.60%36.46%0.80%0.47%

Drawdowns

UTMD vs. DHR - Drawdown Comparison

The maximum UTMD drawdown since its inception was -55.58%, smaller than the maximum DHR drawdown of -65.30%. Use the drawdown chart below to compare losses from any high point for UTMD and DHR.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

UTMD vs. DHR - Volatility Comparison

The current volatility for Utah Medical Products, Inc. (UTMD) is 4.67%, while Danaher Corporation (DHR) has a volatility of 12.02%. This indicates that UTMD experiences smaller price fluctuations and is considered to be less risky than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

UTMD vs. DHR - Financials Comparison

This section allows you to compare key financial metrics between Utah Medical Products, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20212022202320242025
9.71M
5.74B
(UTMD) Total Revenue
(DHR) Total Revenue
Values in USD except per share items

UTMD vs. DHR - Profitability Comparison

The chart below illustrates the profitability comparison between Utah Medical Products, Inc. and Danaher Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%20212022202320242025
57.0%
61.2%
(UTMD) Gross Margin
(DHR) Gross Margin
UTMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Utah Medical Products, Inc. reported a gross profit of 5.54M and revenue of 9.71M. Therefore, the gross margin over that period was 57.0%.

DHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Danaher Corporation reported a gross profit of 3.51B and revenue of 5.74B. Therefore, the gross margin over that period was 61.2%.

UTMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Utah Medical Products, Inc. reported an operating income of 3.15M and revenue of 9.71M, resulting in an operating margin of 32.5%.

DHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Danaher Corporation reported an operating income of 1.27B and revenue of 5.74B, resulting in an operating margin of 22.2%.

UTMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Utah Medical Products, Inc. reported a net income of 3.04M and revenue of 9.71M, resulting in a net margin of 31.3%.

DHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Danaher Corporation reported a net income of 954.00M and revenue of 5.74B, resulting in a net margin of 16.6%.